2026 Q3 Portfolio Activity
In 2026 Q3, DAFNA Capital Management LLC maintained a portfolio of 92 distinct positions. The most significant new addition was BRIDGEBIO ONCOLOGY THERAPEUTIC, now representing 0.23% of the total fund value. They heavily accumulated shares in EUPRAXIA PHARMACEUTICALS INC, increasing the position by 79.3%. The fund also reduced its exposure to ISHARES NASDAQ BIOTECH INDX by 72.8%.
Position History
hover any row below to update
Loading…
Total Positions
92
Quarter
2026 Q3
Top Holding
RVMD (21.4%)
Top 10 Concentration
57.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 92
DAFNA Capital Management LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 21.36% | 20.09% |
#1
Prev: #1
|
6.5 |
—
|
-75,500 | -13.4% |
P
S
|
487,130 | $99,988,304 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ATRC
ATRICURE INC
|
Healthcare | 6.28% | 3.19% |
#2
6
Prev: #8
|
4.5 |
—
|
-74,684 | -12.5% |
P
S
|
522,747 | $29,378,381 | 2012 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 5.68% | 5.43% |
#3
Prev: #3
|
5.3 |
—
|
124,000 | 6.2% |
P
S
|
2,135,952 | $26,571,243 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XBI
SPDR S&P BIOTEC...
|
ETF | 5.10% | 5.93% |
#4
2
Prev: #2
|
2.5 |
—
|
-45,000 | -22.9% |
P
S
|
151,505 | $23,889,308 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 4.18% | 4.24% |
#5
Prev: #5
|
2.7 |
—
|
5,000 | 1.6% |
P
S
|
323,380 | $19,579,042 | 2009 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 3.60% | 3.53% |
#6
1
Prev: #7
|
1.9 |
—
|
-58,500 | -11.8% |
P
S
|
438,740 | $16,856,391 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STXS
STEREOTAXIS INC
|
Healthcare | 3.60% | 4.49% |
#7
3
Prev: #4
|
2.4 |
—
|
no change | no change |
P
S
|
13,680,554 | $16,827,081 | 2012 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 3.29% | 3.62% |
#8
2
Prev: #6
|
1.8 |
—
|
5,000 | 0.7% |
P
S
|
744,014 | $15,378,769 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 2.43% | 2.47% |
#9
3
Prev: #12
|
1.5 |
—
|
1,500 | 3.1% |
P
S
|
49,969 | $11,384,437 | 2015 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 2.43% | 2.60% |
#10
1
Prev: #11
|
1.5 |
—
|
-2,000 | -0.5% |
P
S
|
439,829 | $11,360,783 | 2018 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.42% | 2.79% |
#11
1
Prev: #10
|
2.0 |
—
|
no change | no change |
P
S
|
171,998 | $11,336,388 | 2015 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.92% | 1.76% |
#12
4
Prev: #16
|
1.3 |
—
|
-5,000 | -2.2% |
P
S
|
221,819 | $9,005,851 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 1.90% | 1.86% |
#13
Prev: #13
|
2.8 |
—
|
4,947 | 8.6% |
P
S
|
62,716 | $8,895,637 | 2008 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PODD
INSULET CORP
|
Healthcare | 1.89% | 1.80% |
#14
1
Prev: #15
|
2.8 |
—
|
6,000 | 9.7% |
P
S
|
67,870 | $8,854,999 | 2008 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.63% | 2.89% |
#15
6
Prev: #9
|
1.2 |
—
|
-46,000 | -18.3% |
P
S
|
204,772 | $7,615,471 | 2015 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 1.61% | 1.84% |
#16
2
Prev: #14
|
1.1 |
—
|
-29,000 | -13.9% |
P
S
|
179,960 | $7,543,923 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.59% | 1.11% |
#17
6
Prev: #23
|
1.6 |
—
|
no change | no change |
P
S
|
86,279 | $7,445,015 | 2012 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.33% | 1.40% |
#18
1
Prev: #19
|
1.0 |
—
|
-3,965 | -1.2% |
P
S
|
331,290 | $6,228,252 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 1.29% | 1.17% |
#19
2
Prev: #21
|
1.0 |
—
|
-120,009 | -6.0% |
P
S
|
1,888,155 | $6,032,655 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 1.24% | 1.02% |
#20
6
Prev: #26
|
1.5 |
—
|
no change | no change |
P
S
|
355,208 | $5,793,442 | 2015 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 1.19% | 1.61% |
#21
4
Prev: #17
|
2.5 |
—
|
15,000 | 5.3% |
P
S
|
299,955 | $5,582,163 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 1.02% | 0.60% |
#22
12
Prev: #34
|
3.4 |
—
|
66,900 | 89.2% |
P
S
|
141,900 | $4,767,840 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.98% | 1.10% |
#23
1
Prev: #24
|
0.9 |
—
|
-14,000 | -9.4% |
P
S
|
135,524 | $4,578,001 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INGN
INOGEN INC
|
Healthcare | 0.95% | 1.04% |
#24
1
Prev: #25
|
1.4 |
—
|
no change | no change |
P
S
|
845,179 | $4,454,093 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NGNE
NEUROGENE INC
|
Healthcare | 0.89% | 0.53% |
#25
12
Prev: #37
|
3.4 |
—
|
61,500 | 69.1% |
P
S
|
150,532 | $4,187,800 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.88% | 1.01% |
#26
1
Prev: #27
|
1.4 |
—
|
no change | no change |
P
S
|
101,266 | $4,103,298 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.87% | 1.12% |
#27
5
Prev: #22
|
0.8 |
—
|
-13,708 | -0.6% |
P
S
|
2,386,750 | $4,081,343 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KIDS
ORTHOPEDIATRICS...
|
Healthcare | 0.85% | 0.69% |
#28
4
Prev: #32
|
0.8 |
—
|
-10,000 | -5.3% |
P
S
|
179,130 | $3,989,225 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GLPG
LAKEFRONT BIOTH...
|
Healthcare | 0.82% | 0.74% |
#29
2
Prev: #31
|
1.3 |
—
|
no change | no change |
P
S
|
130,175 | $3,859,689 | 2015 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.81% | 0.82% |
#30
2
Prev: #28
|
2.3 |
—
|
15,260 | 11.7% |
P
S
|
146,135 | $3,799,510 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANL
ADLAI NORTYE GR...
|
Healthcare | 0.80% | 0.53% |
#31
7
Prev: #38
|
0.8 |
—
|
-6,790 | -2.8% |
P
S
|
232,763 | $3,724,208 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 0.79% | 0.28% |
#32
23
Prev: #55
|
3.3 |
—
|
178,967 | 79.3% |
P
S
|
404,567 | $3,681,560 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.75% | 0.49% |
#33
8
Prev: #41
|
3.3 |
—
|
39,600 | 57.8% |
P
S
|
108,118 | $3,504,104 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 0.68% | 0.79% |
#34
5
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
2,000,000 | $3,200,000 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 0.68% | 0.76% |
#35
5
Prev: #30
|
0.8 |
—
|
-20,000 | -5.0% |
P
S
|
380,248 | $3,167,466 | 2014 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.64% | 0.59% |
#36
1
Prev: #35
|
0.8 |
—
|
-88 | -0.3% |
P
S
|
26,912 | $3,008,492 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 0.63% | 0.51% |
#37
3
Prev: #40
|
0.8 |
—
|
-5,000 | -0.8% |
P
S
|
640,915 | $2,967,436 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
ATRIUM THERAPEU...
|
|
Unknown | 0.53% | 0.33% |
#38
13
Prev: #51
|
3.2 |
—
|
172,076 | 134.4% |
P
S
|
300,076 | $2,484,629 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
IBB
ISHARES NASDAQ ...
|
ETF | 0.52% | 1.54% |
#39
21
Prev: #18
|
0.2 |
—
|
-31,000 | -72.8% |
P
S
|
11,595 | $2,441,095 | 2006 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 0.47% | 0.52% |
#40
1
Prev: #39
|
1.2 |
—
|
no change | no change |
P
S
|
120,000 | $2,186,400 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRQR
PROQR THERAPEUT...
|
Healthcare | 0.47% | 0.54% |
#41
5
Prev: #36
|
0.7 |
—
|
-217,831 | -14.2% |
P
S
|
1,312,530 | $2,178,800 | 2017 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.46% | 0.65% |
#42
9
Prev: #33
|
0.2 |
—
|
-338,359 | -65.8% |
P
S
|
175,702 | $2,159,378 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.43% | 0.45% |
#43
Prev: #43
|
1.2 |
—
|
no change | no change |
P
S
|
14,000 | $2,034,900 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.38% | 0.44% |
#44
Prev: #44
|
0.7 |
—
|
-5,000 | -8.4% |
P
S
|
54,516 | $1,777,222 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 0.38% | 0.37% |
#45
2
Prev: #47
|
1.2 |
—
|
no change | no change |
P
S
|
65,000 | $1,766,700 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.36% | 0.35% |
#46
2
Prev: #48
|
1.1 |
—
|
no change | no change |
P
S
|
908,351 | $1,680,449 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TELA
TELA BIO INC
|
Healthcare | 0.35% | 0.21% |
#47
16
Prev: #63
|
1.1 |
—
|
no change | no change |
P
S
|
1,441,029 | $1,657,183 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 0.34% | 1.17% |
#48
28
Prev: #20
|
0.6 |
—
|
-15,427 | -9.0% |
P
S
|
155,579 | $1,585,350 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NGENF
NERVGEN PHARMA ...
|
Unknown | 0.33% | 0.41% |
#49
4
Prev: #45
|
0.1 |
—
|
-239,138 | -22.8% |
P
S
|
810,862 | $1,548,746 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.31% | 0.48% |
#50
8
Prev: #42
|
1.1 |
—
|
no change | no change |
P
S
|
46,500 | $1,454,055 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 92 holdings